1402 related articles for article (PubMed ID: 16598384)
1. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.
Bae JS; Gutierrez S; Narla R; Pratap J; Devados R; van Wijnen AJ; Stein JL; Stein GS; Lian JB; Javed A
J Cell Biochem; 2007 Feb; 100(2):434-49. PubMed ID: 16927309
[TBL] [Abstract][Full Text] [Related]
4. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
5. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation.
Yang S; Wei D; Wang D; Phimphilai M; Krebsbach PH; Franceschi RT
J Bone Miner Res; 2003 Apr; 18(4):705-15. PubMed ID: 12674331
[TBL] [Abstract][Full Text] [Related]
8. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling.
Osyczka AM; Leboy PS
Endocrinology; 2005 Aug; 146(8):3428-37. PubMed ID: 15905316
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
12. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
13. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.
Kim BS; Kang HJ; Park JY; Lee J
Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360
[TBL] [Abstract][Full Text] [Related]
14. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
15. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal.
Javed A; Bae JS; Afzal F; Gutierrez S; Pratap J; Zaidi SK; Lou Y; van Wijnen AJ; Stein JL; Stein GS; Lian JB
J Biol Chem; 2008 Mar; 283(13):8412-22. PubMed ID: 18204048
[TBL] [Abstract][Full Text] [Related]
16. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB.
Eliseev RA; Schwarz EM; Zuscik MJ; O'Keefe RJ; Drissi H; Rosier RN
Exp Cell Res; 2006 Jan; 312(1):40-50. PubMed ID: 16259979
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
19. L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin.
Albers CE; Hofstetter W; Sebald HJ; Sebald W; Siebenrock KA; Klenke FM
Bone; 2012 Sep; 51(3):401-6. PubMed ID: 22750402
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo osteoblastic differentiation of BMP-2- and Runx2-engineered skeletal myoblasts.
Gersbach CA; Guldberg RE; García AJ
J Cell Biochem; 2007 Apr; 100(5):1324-36. PubMed ID: 17131362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
